REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Ziff, M. [1 ]
Cheesman, S. [1 ]
Kyriakou, C. [1 ]
Mehta, A. [1 ]
Papanikolaou, X. [1 ]
Rabin, N. [1 ]
Wechalekar, A. [1 ]
Yong, K. [1 ]
Popat, R. [1 ]
机构：
[1] Univ Coll London Hosp NHS Fdn Trust, London, England
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1975
引用
收藏
页码：786 / 787
页数：2
相关论文
共 50 条
  • [11] Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
    Macro, M.
    Hulin, C.
    Vincent, L.
    Charvet-Rumpler, A.
    Benboubker, L.
    Calmettes, C.
    Stoppa, A. -m.
    Laribi, K.
    Clement-Filliatre, L.
    Zerazhi, H.
    Honeyman, F.
    Richez, V.
    Maloisel, F.
    Karlin, L.
    Barrak, J.
    Chouaid, C.
    Leleu, X.
    ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2137 - 2151
  • [12] Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study
    Kim, Do Young
    Shin, Ho-Jin
    Min, Chang-Ki
    Eom, Hyeon-Seok
    Jung, Jongheon
    Kim, Kihyun
    Lee, Jae Hoon
    Yoo, Kwai Han
    Lee, Ji Yun
    Byun, Ja Min
    Kim, Sung-Hyun
    Lee, Ji Hyun
    Cho, Hee Jeong
    Lee, Sang Min
    Do, Young Rok
    Park, Sungwoo
    Lee, Junglim
    Lee, Seung-Shin
    Kang, Hye Jin
    Park, Young Hoon
    Lim, Sung-Nam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S189 - S190
  • [13] Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis
    Stork, Martin
    Spicka, Ivan
    Radocha, Jakub
    Minarik, Jiri
    Jelinek, Tomas
    Jungova, Alexandra
    Pavlicek, Petr
    Pospisilova, Lenka
    Sedlak, Frantisek
    Straub, Jan
    Pika, Tomas
    Knechtova, Zdenka
    Fidrichova, Anna
    Boichuk, Ivanna
    Sevcikova, Sabina
    Maisnar, Vladimir
    Hajek, Roman
    Pour, Ludek
    ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1501 - 1511
  • [14] Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
    Martin Stork
    Ivan Spicka
    Jakub Radocha
    Jiri Minarik
    Tomas Jelinek
    Alexandra Jungova
    Petr Pavlicek
    Lenka Pospisilova
    Frantisek Sedlak
    Jan Straub
    Tomas Pika
    Zdenka Knechtova
    Anna Fidrichova
    Ivanna Boichuk
    Sabina Sevcikova
    Vladimir Maisnar
    Roman Hajek
    Ludek Pour
    Annals of Hematology, 2023, 102 : 1501 - 1511
  • [15] BUDGET IMPACT OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN RUSSIA
    Pyadushkina, E.
    Derkach, E., V
    Boyarskaya, T.
    VALUE IN HEALTH, 2018, 21 : S26 - S26
  • [16] BUDGET IMPACT OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN BRAZIL
    Sakagute, M.
    Tanaka, P. Y.
    Duva, A.
    Rigolon, J.
    VALUE IN HEALTH, 2019, 22 : S459 - S459
  • [17] REAL-WORLD EXPERIENCE OF LENALIDOMIDE/DEXAMETHASONE TREATMENT FOR REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM) PATIENTS
    Tognazzi, L.
    Rivolti, E.
    Quaresima, M.
    Labbozzetta, S.
    Gamberi, B.
    Merli, F.
    HAEMATOLOGICA, 2017, 102 : 137 - 137
  • [18] "REAL WORLD" DATA ON THE EFFICACY AND SAFETY OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A STUDY OF THE GREEK MYELOMA STUDY GROUP
    Terpos, E.
    Katodritou, E.
    Kotsopoulou, M.
    Ntanasis-Stathopoulos, I.
    Lampropoulou, P.
    Papadaki, S.
    Papathanasiou, M.
    Stoumbos, D.
    Gavriatopoulou, M.
    Repousis, P.
    Kastritis, E.
    Dimopoulos, M. A.
    HAEMATOLOGICA, 2017, 102 : 511 - 512
  • [19] Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma
    Kumar, Shaji
    Moreau, Philippe
    Hari, Parameswaran
    Mateos, Maria-Victoria
    Ludwig, Heinz
    Shustik, Chaim
    Masszi, Tamas
    Spencer, Andrew
    Hajek, Roman
    Romeril, Kenneth
    Avivi, Irit
    Liberati, Anna M.
    Minnema, Monique C.
    Einsele, Hermann
    Lonial, Sagar
    Berg, Deborah
    Lin, Jianchang
    Gupta, Neeraj
    Esseltine, Dixie-Lee
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (04) : 571 - 582
  • [20] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
    Dimopoulos, Meletios
    Spencer, Andrew
    Attal, Michael
    Prince, H. Miles
    Harousseau, Jean-Luc
    Dmoszynska, Anna
    San Miguel, Jesus
    Hellmann, Andrzej
    Facon, Thierry
    Foa, Robin
    Corso, Alessandro
    Masliak, Zvenyslava
    Olesnyckyj, Marta
    Yu, Zhinuan
    Patin, John
    Zeldis, Jerome B.
    Knight, Robert D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132
12345